Expression of p16 protein in gallbladder carcinoma and its precancerous conditions

Hepato-Gastroenterology

Volumn 57, Issue 97, 2010, Pages 18-21

  Choi, Hye Jeong ^a   Yun, Sung Su ^b   Kim, Hong Jin ^b   Choi, Joon Hyuk ^b  

^a University of Ulsan College of Medicine   (South Korea)

^b Yeungnam University College of Medicine   (South Korea)

Author keywords

Gallbladder carcinoma; Immunohistochemistry; p16; Precancerous conditions

Indexed keywords

PROTEIN P16;

ADULT; AGED; ARTICLE; CANCER STAGING; CARCINOGENESIS; CHRONIC CHOLECYSTITIS; CONTROLLED STUDY; FEMALE; GALLBLADDER; GALLBLADDER ADENOCARCINOMA; GALLBLADDER CARCINOGENESIS; GALLBLADDER CARCINOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; TUMOR LOCALIZATION; TUMOR VOLUME;

ADENOMA; AGED; BIOLOGICAL MARKERS; CARCINOMA; CASE-CONTROL STUDIES; CHOLECYSTITIS; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PRECANCEROUS CONDITIONS; SURVIVAL RATE;

EID: 77952008383     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Dowling G, Kelly J: The histogenesis of adenocarcinoma of the gallbladder. Cancer 1986; 58:1702-1708.
2. Albores-Saavedra J,Henson DE, Kimstra DS: Tumors of the Gallbladder, Extrahepatic Bile Ducts, and Ampulla of Vater. Atlas of tumor pathology. 3rd series, Fascicle 27, Washington D.C. Armed Forces of Institute of Pathology, 2000, 37-49.
3. Wistuba II, Albores-Saavedra J: Genetic abnormalities involved in the pathogenesis of gallbladder carcinoma. J Hepatobiliary Pancreat Surg 1999; 6:237-244.
4. Ueki T, Hsing AW, Gao YT, Wang BS, Shen MC, Cheng J, Deng J, Fraumeni JF Jr, Rashid A: Alterations of p16 and prognosis in biliary tract cancers from a population-based study in China. Clin Cancer Res 2004; 10:1717-1725. (Pubitemid 38435563)
5. Yoshida S, Todoroki T, Ichikawa Y, Hanai S, Suzuki H, Hori M, Fukao K, Miwa M, Uchida K: Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers. Cancer Res 1995; 55:2756-2760.
6. Albores-Saavedra J, Scoazec JC, Wittekind C, Sripa B, Menck HR, Soehendra N, Sriram PVJ: Carcinoma of the gallbladder and extrahepatic bile ducts. In: Hamilton SR, Aaltonen LA, eds. WHO classification of tumors. Pathology and genetics of tumors of the digestive system. Lyon, IARC Press. 2000, 206-214.
7. Kim YT, Kim J, Jang YH, Lee WJ, Ryu JK, Park YK, Kim SW, Kim WH, Yoon YB, Kim CY: Genetic alterations in gallbladder adenoma, dysplasia and carcinoma. Cancer Lett 2001; 169:59-68. (Pubitemid 32532097)
8. Shi YZ, Hui AM, Li X, Takayama T, Makuuchi M: Overexpression of retinoblastoma protein predicts decreased survival and correlates with loss of p16INK4 protein in gallbladder carcinomas. Clin Cancer Res 2000; 6:4096-4100.
9. Parwani AV, Geradts J, Caspers E, Offerhaus GJ, Yeo CJ, Cameron JL, Klimstra DS, Maitra A, Hruban RH, Argani P: Immunohistochemical and genetic analysis of non-small cell and small cell gallbladder carcinoma and their precursor lesions. Mod Pathol 2003; 16:299-308. (Pubitemid 36443978)
10. Lynch BC, Lathrop SL, Ye D, Ma TY, Cerilli LA: Expression of the p16 (INK4a) gene product in premalignant and malignant epithelial lesions of the gallbladder. Ann Diagn Pathol 2008; 12:161-164. (Pubitemid 351672097)
11. Kong CS, Balzer BL, Troxell ML, Patterson BK, Longacre TA: p16INK4A immunohistochemistry is superior to HPV in situ hybridization for the detection of high-risk HPV in atypical squamous metaplasia. Am J Surg Pathol 2007; 31:33-43.
12. Lambert AP, Anschau F, Schmitt VM: p16INK4A expression in cervical premalignant and malignant lesions. Exp Mol Pathol 2006; 80:192-196. (Pubitemid 43295540)
13. Gold KA, Kim ES: Role of molecular markers and gene profiling in head and neck cancers. Curr Opin Oncol 2009; 21:206-211.